All About Oxandrolone

Buy Lab Tests Online
Status
Not open for further replies.
Defy Medical TRT clinic doctor

SteveCleves

Well-Known Member
That drug did a lot of good for women with HIV wasting. Here is a presentation I gave at a conference in Cannes.

I wonder how much its used now that HIV has become a manageable disease. I don't know, but is wasting still an issue with the current HIV treatments?

So it seems like the only mainstream use case is burn victims? I would be curious to know how much it's even used in those cases.
 

Nelson Vergel

Founder, ExcelMale.com
Oxandrolone is the most studied androgen besides testosterone. I am attaching a great review of data from many studies that found no liver toxicity. Some reversible transient AST and ALT elevations (which we have also seen with resistance exercise alone) were seen in a few studies. Read page 737 on.

oxandrolone liver.jpg
 

Attachments

  • The_Anabolic_Androgenic_Steroid_Oxandrolone_in_the.4.pdf
    199.5 KB · Views: 51

Nelson Vergel

Founder, ExcelMale.com
Great find ! @readalot

I guess compounders will have to fill a Citizens Petition for oxandrolone. Something tells me it will not have the same outcome as nandrolone unless they do a good job at explaining that hepatic effects are seen at high doses and long term exposure.
 
T

tareload

Guest
would be curious to know how much it's even used in those cases.
Pretty good amount of recent literature in this burn group. Very useful tool.

@Nelson Vergel probobaly not needed but happy to help with lit review refuting the BS above. Not a very scholarly review of what is available in the Fed Register link from madman's post but of course that was not the purpose.
 
T

tareload

Guest
@SteveCleves






Liver injury?...
5 years at 50 to 100 mg/day maybe. Not applicable to clinical use.Of course the lipids would be my primary concern.

Another railroading by FDA. Pathetic review of data and literature to date in June 23 memo.
 
T

tareload

Guest
Comprehensive list all in one spot:

 

Nelson Vergel

Founder, ExcelMale.com
Any thoughts, comments, or edits? Planning to send this letter.

Alexandria Fujisaki
Regulatory Counsel, CDER
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
United States

Dear Ms. Fujisaki,

I am writing to express deep concern over the recent decision to notify oxandrolone manufacturers that the FDA believes the potential risks associated with this drug are severe enough to warrant its removal from the market. As an informed citizen, I would like to present a case that highlights the important positive and safe uses of oxandrolone for various medical conditions.

Oxandrolone, a synthetic derivative of testosterone, has been used effectively to promote weight gain in patients experiencing HIV wasting syndrome. Several studies, such as that by Grunfeld et al. (2006)[1], have demonstrated that oxandrolone, along with adequate nutrition, significantly increases body cell mass and muscle size in these patients with no hepatotoxicity.

Furthermore, this medication has been safely used to counteract protein catabolism caused by long-term corticosteroid therapy (Goldberg, et al., 1996)[2]. It's also proven to be effective in supporting recovery from severe burns, greatly improving lean body mass, bone mineral content, and muscle strength (Jeschke, et al., 2005)[3].

Notably, oxandrolone is used for the treatment of bone pain related to osteoporosis, enhancing both bone density and quality of life in patients (Bonaiuti, et al., 2002)[4]. It also plays a significant role in the development of girls with Turner syndrome, boosting height velocity and adult height (Menke & Sas, 2010)[5].

Safety and side effect profiles are important considerations for any medication, and it is crucial to remember that oxandrolone has been found to have a favorable safety profile. Studies have demonstrated no liver toxicity when used at clinically effective doses (Schänzer, 1996)[6]. Moreover, oxandrolone has shown minimal virilizing side effects, making it an appropriate choice for pediatric and female patients (Sheffield-Moore, et al., 2011)[7].

While I understand the FDA's responsibility is to safeguard public health, it's essential to thoroughly examine the balance between benefits and risks in real-world clinical contexts. Considering the extensive body of research supporting the efficacy and safety of oxandrolone, I urge you to reconsider this decision. The decision to withdraw a drug from the market should not be taken lightly, especially when it has proven beneficial for many patients who rely on it for necessary treatment.

I appreciate your attention to this matter and look forward to your response.

Sincerely,

Nelson Vergel
Founder, Program for Wellness Restoration
A 501 (c) 3 Organization

References:
[1] Grunfeld, C., et al. (2006). Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. Journal of Acquired Immune Deficiency Syndromes, 41(3), p.304-314.
[2] Goldberg, A. L., et al. (1996). Effects of Oxandrolone on Protein Metabolism in Burned Children. Nutrition in Clinical Practice, 11(1), p. 29-35.
[3] Jeschke, M. G., et al. (2005). The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg. 242(3): p. 384-91.
[4] Bonaiuti, D., et al. (2002). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. (3): CD000333.
[5] Menke LA, Sas TC. (2010). The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome. Clin Endocrinol (Oxf). 73(2): p. 212-9.
[6] Schänzer, W. (1996). Metabolism of anabolic androgenic steroids. Clin Chem. 42(7): p. 1001-20.
[7] Sheffield-Moore, M., et al. (2011). Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. Journal of Clinical Endocrinology & Metabolism, 86(8), p. 3485-3491.
 
T

tareload

Guest
Any thoughts, comments, or edits? Planning to send this letter.

Alexandria Fujisaki
Regulatory Counsel, CDER
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
United States

Dear Ms. Fujisaki,

I am writing to express deep concern over the recent decision to notify oxandrolone manufacturers that the FDA believes the potential risks associated with this drug are severe enough to warrant its removal from the market. As an informed citizen, I would like to present a case that highlights the important positive and safe uses of oxandrolone for various medical conditions.

Oxandrolone, a synthetic derivative of testosterone, has been used effectively to promote weight gain in patients experiencing HIV wasting syndrome. Several studies, such as that by Grunfeld et al. (2006)[1], have demonstrated that oxandrolone, along with adequate nutrition, significantly increases body cell mass and muscle size in these patients with no hepatotoxicity.

Furthermore, this medication has been safely used to counteract protein catabolism caused by long-term corticosteroid therapy (Goldberg, et al., 1996)[2]. It's also proven to be effective in supporting recovery from severe burns, greatly improving lean body mass, bone mineral content, and muscle strength (Jeschke, et al., 2005)[3].

Notably, oxandrolone is used for the treatment of bone pain related to osteoporosis, enhancing both bone density and quality of life in patients (Bonaiuti, et al., 2002)[4]. It also plays a significant role in the development of girls with Turner syndrome, boosting height velocity and adult height (Menke & Sas, 2010)[5].

Safety and side effect profiles are important considerations for any medication, and it is crucial to remember that oxandrolone has been found to have a favorable safety profile. Studies have demonstrated no liver toxicity when used at clinically effective doses (Schänzer, 1996)[6]. Moreover, oxandrolone has shown minimal virilizing side effects, making it an appropriate choice for pediatric and female patients (Sheffield-Moore, et al., 2011)[7].

While I understand the FDA's responsibility is to safeguard public health, it's essential to thoroughly examine the balance between benefits and risks in real-world clinical contexts. Considering the extensive body of research supporting the efficacy and safety of oxandrolone, I urge you to reconsider this decision. The decision to withdraw a drug from the market should not be taken lightly, especially when it has proven beneficial for many patients who rely on it for necessary treatment.

I appreciate your attention to this matter and look forward to your response.

Sincerely,

Nelson Vergel
Founder, Program for Wellness Restoration
A 501 (c) 3 Organization

References:
[1] Grunfeld, C., et al. (2006). Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. Journal of Acquired Immune Deficiency Syndromes, 41(3), p.304-314.
[2] Goldberg, A. L., et al. (1996). Effects of Oxandrolone on Protein Metabolism in Burned Children. Nutrition in Clinical Practice, 11(1), p. 29-35.
[3] Jeschke, M. G., et al. (2005). The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg. 242(3): p. 384-91.
[4] Bonaiuti, D., et al. (2002). Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. (3): CD000333.
[5] Menke LA, Sas TC. (2010). The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome. Clin Endocrinol (Oxf). 73(2): p. 212-9.
[6] Schänzer, W. (1996). Metabolism of anabolic androgenic steroids. Clin Chem. 42(7): p. 1001-20.
[7] Sheffield-Moore, M., et al. (2011). Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. Journal of Clinical Endocrinology & Metabolism, 86(8), p. 3485-3491.


 

Wilson7

Active Member
Political IMO. If it weren't a drug that is abused for cosmetic reasons, they would leave it alone. Unfortunate for those that could benefit from it clinically (cachexia, sarcopenia, recovery from surgery esp involving skeletal muscle and injury, etc.). Regardless, it just forces more people into the underground marketplace where oxandrolone is readily available and that simply increases the risks. I have not seen one study or case report that has shown serious liver issues with oxandrolone alone in dosing 20 mg/d or less in any population. Many drugs increase ALT/AST, while it should be followed, that doesn't necessarily mean that significant liver damage is occurring. I have a client on Gilenya for MS, ALT/AST in the low 100's for years, no evidence of liver dysfunction, scans normal. Even her doc admits that despite a large number of patients showing elevated LFTs on Gilenya, they are all doing fine. That doesn't mean everyone will do fine, just have to leave the drama out and stick with the facts.
 
T

tareload

Guest
My posts have an interesting habit of disappearing. Must be my humor? The last one was actually serious.

If there is any feedback on what I should not say let me know so I save my time in the future.
 
T

tareload

Guest
The last one was too sarcastic and did not help the discussion. I enjoy your smarts but sometimes some of you get too cocky for my taste (I am ExcelMale's dictator LOL)
Well if it came from you then I will have to take it! Thanks for the reply.

LOL.

Edit: I find humor to be helpful in dealing with many of situations we find today. I realize you wrote "some of you": however, I can only assure you it is not my intent to be cocky on here. I try to hold myself to highest standard of presenting scientifically accurate info and analysis. I of course defer to your wishes as this is your site and will turn down the volume my poor humor.

Thanks for the feedback.
 
Last edited by a moderator:

Charliebizz

Well-Known Member
Can anyone tell me oxandrolone effects on cortisol in layman’s terms. I recently did a short trial. Admittedly it was ugl and not sure if it’s actually oxandrolone. But it really effected my performance at hockey. And overall I haven’t felt great. I have dr prescribed oxandrolone coming next week but now I’m kind of afraid to take it.
 
Status
Not open for further replies.
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

enclomiphene
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
11
Guests online
6
Total visitors
17

Latest posts

bodybuilder test discounted labs
Top